Exchanges: NASDAQ | NYSE | XLON | AMS | ADS | TSE | BRU

Financial News Feed

Stronger Sell Today AMAG ranks #4304 as SELL CANDIDATE #4304 Weaker Sell

AMAG stock forecast AMAG Pharmaceuticals

AMAG stock forecast

AMAG Pharmaceuticals (AMAG) announces that the FDA has approved Vyleesi to treat acquired, generalized hypoactive sexual desire disorder in premenopausal women.

Read more

Shares of the two companies behind Vyleesi, the newly approved women’s libido drug, tumbled Monday. Both AMAG Pharmaceuticals and Palatin Technologies stock suffered steep losses.

Read more

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 20) Abbott Laboratories (NYSE: ABT ) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL ) Celgene Corporation (NASDAQ: CELG ) Coherus Biosciences Inc (NASDAQ: CHRS ) DiaMedica Therapeutics Inc (NASDAQ: DMAC )( reported positive interim results from a Phase 1b study of its DM199, which is being evaluated for moderate-to-severe chronic kidney disease) Edesa Biotech Inc (NASDAQ: EDSA )(FDA gave the go ahead to start a Phase 2b trial for EB01, its lead candidate being evaluated for chronic allergic contact dermatitis) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Hologic, Inc. (NASDAQ: HOLX ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc. (NYSE: RMD ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech stocks hitting 52-week lows on June 20) Abeona Therapeutics Inc (NASDAQ: ABEO ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) AMAG Pharmaceuticals, Inc.

Read more

AMAG Pharmaceuticals (AMAG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Read more

AMAG Pharmaceuticals (AMAG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Read more

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 29) Chiasma Inc (NASDAQ: CHMA ) Soliton Inc (NASDAQ: SOLY )( reacted to the news of the initiation of cellulite trial) Eidos Therapeutics Inc (NASDAQ: EIDX ) Down In The Dumps (Biotech stocks hitting 52-week lows on May 29) Abeona Therapeutics Inc (NASDAQ: ABEO ) Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Alkermes Plc (NASDAQ: ALKS ) Allena Pharmaceuticals Inc (NASDAQ: ALNA ) Allergan plc (NYSE: AGN ) AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) Aptinyx Inc (NASDAQ: APTX ) Arbutus Biopharma Corp (NASDAQ: ABUS ) Axovant Gene Therapies Ltd (NASDAQ: AXGT ) BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) CAN-FITE BIOPHA/S ADR (NYSE: CANF )(reacted to its first-quarter results and an update on clinical trial progress) Cidara Therapeutics Inc (NASDAQ: CDTX ) Diplomat Pharmacy Inc (NYSE: DPLO ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Emergent Biosolutions Inc (NYSE: EBS ) Foamix Pharmaceuticals Ltd (NASDAQ: FOMX ) Hookipa Pharma Inc (NASDAQ: HOOK ) IMMURON LTD/S ADR (NASDAQ: IMRN ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) Melinta Therapeutics Inc (NASDAQ: MLNT ) Opko Health Inc. (NASDAQ: OPK ) Sellas Life Sciences Group Inc (NASDAQ: SLS ) Seres Therapeutics Inc (NASDAQ: MCRB ) Teva Pharmaceutical Industries Ltd (NYSE: TEVA )( downgraded by UBS to Neutral on its legal woes) Theravance Biopharma Inc (NASDAQ: TBPH ) Xenetic Biosciences Inc (NASDAQ: XBIO ) Stock In Focus Unity …

Read more

AMAG earnings call for the period ending March 31, 2019.

Read more

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Q1 2019 Earnings Conference Call May 07, 2019 08:00 AM ET Company Participants Linda Lennox - IR Bill Heiden - Presiden

Read more

AMAG Pharmaceuticals EPS of -$3.54
11:09am, Tuesday, 07'th May 2019

Read more

AMAG Pharmaceuticals (AMAG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Read more

During Q4 2018 the big money sentiment increased to 1.23. That's change of 0.01, from 2018Q3's 1.22. 16 investors sold all, 53 reduced holdings as AMAG

Read more

Fine tuning their focus in on AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) stock, investors are taking a closer look at the equity in recent weeks. Most recently the shares moved -1.00% landing at a price

Read more

Here we will take a look at several key ratios for Presidio, Inc. (NasdaqGS:PSDO), starting with the Book to Market (BTM) ratio. Value investors seek stocks with high BTMs for their portfolios. The ra

Read more

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank